The new antibody that may be able to stay ‘one step ahead’ of coronavirus mutations
A new antibody that can mount a double attack on the Sars-CoV-2 virus by binding to two different sites on the spike protein is starting human trials, leading to hopes of an antibody therapy that can maintain its effectiveness even against new variants of coronavirus. A virus is constantly mutating. Staying ahead of the evolutionary … Read more